Cargando…

Diagnostic performance of interferon-Gamma assay for tuberculosis in immunocompromised patients

Detalles Bibliográficos
Autores principales:	Su, Shih-Yang, Chao, Chien-Ming, Lai, Chih-Cheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2013
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573562/ https://www.ncbi.nlm.nih.gov/pubmed/23437019 http://dx.doi.org/10.4103/1817-1737.105723

Ejemplares similares

Diagnostic Value of Interferon-Gamma Release Assays for Tuberculosis in the Immunocompromised Population
por: Yang, Ying, et al.
Publicado: (2022)

Interferon-Gamma Release Assay in a Patient with Tuberculosis Verrucosa Cutis
por: Kim, Geon, et al.
Publicado: (2015)

Interferon gamma release assay and tuberculin skin test positivity in sarcoidosis
por: Vyas, Sunil, et al.
Publicado: (2015)

Interferon-Gamma Release Assay Performance in Pulmonary and Extrapulmonary Tuberculosis
por: Feng, Yun, et al.
Publicado: (2012)

Interferon-gamma release assay as a diagnostic test for tuberculosis-associated uveitis
por: Ang, M, et al.
Publicado: (2012)

Diagnostic Performance of Interferon-Gamma Releasing Assay in HIV-Infected Patients in China
por: Yu, Yanhua, et al.
Publicado: (2013)

Effects of acute critical illnesses on the performance of interferon-gamma release assay
por: Huang, Chun-Ta, et al.
Publicado: (2016)

Interferon-Gamma Release Assay Performance of Pleural Fluid and Peripheral Blood in Pleural Tuberculosis
por: Liu, Fei, et al.
Publicado: (2013)

The Use of Interferon Gamma Release Assays in the Diagnosis of Active Tuberculosis
por: Vesenbeckh, Silvan M., et al.
Publicado: (2012)

Increasing legionella in Taiwan during COVID-19 pandemic
por: Chao, Chien-Ming, et al.
Publicado: (2022)

Performance of the Interferon Gamma Release Assays in Tuberculosis Disease in Children Five Years Old or Less
por: Sun, Lin, et al.
Publicado: (2015)

Population tailored modification of tuberculosis specific interferon-gamma release assay
por: Horvati, Kata, et al.
Publicado: (2016)

Duration of isolation and precautions in immunocompromised patients with COVID-19
por: Taramasso, L., et al.
Publicado: (2021)

Performance of interferon-gamma levels may lead to earlier diagnosing macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
por: Lu, Meiping, et al.
Publicado: (2023)

Performance of the tuberculin skin test and interferon-γ release assay for detection of tuberculosis infection in immunocompromised patients in a BCG-vaccinated population
por: Kim, Eun Young, et al.
Publicado: (2009)

Helicobacter pylori and Immunocompromised Children
por: Nutpho, Prakaimuk, et al.
Publicado: (2006)

Three patients with defects in interferon gamma receptor signaling: A challenging diagnosis
por: Zhou, Zijun, et al.
Publicado: (2022)

The clinical efficacy of lefamulin in the treatment of elderly patients with community-acquired bacterial pneumonia
por: Tang, Hung-Jen, et al.
Publicado: (2020)

Sofosbuvir/daclatasvir in the treatment of COVID-19 infection: A meta-analysis
por: Chan, Huan-Tee, et al.
Publicado: (2021)

Clinical efficacy and safety of favipiravir in the treatment of COVID-19 patients
por: Chen, Ping-Jen, et al.
Publicado: (2021)

The COVID-19 pandemic and tuberculosis in Taiwan
por: Lai, Chih-Cheng, et al.
Publicado: (2020)

Chest roentgenography is complementary to interferon-gamma release assay in latent tuberculosis infection screening of rheumatic patients
por: Wang, Ping-Huai, et al.
Publicado: (2020)

Interferon-gamma release assay has poor diagnostic accuracy in differentiating intestinal tuberculosis from Crohn’s disease in tuberculosis endemic areas
por: Sachdeva, Karan, et al.
Publicado: (2023)

Evaluation of the performance of two tuberculosis interferon gamma release assays (IGRA-ELISA and T-SPOT.TB) for diagnosing Mycobacterium tuberculosis infection
por: Wang, Linchuan, et al.
Publicado: (2018)

Feasibility, acceptability, and cost of tuberculosis testing by whole-blood interferon-gamma assay
por: Dewan, Puneet Kumar, et al.
Publicado: (2006)

Risk Stratification of Latent Tuberculosis Defined by Combined Interferon Gamma Release Assays
por: Corbière, Véronique, et al.
Publicado: (2012)

The Usefulness of Interferon-gamma Release Assay for Diagnosis of Tuberculosis-related Uveitis in Korea
por: Ahn, Seong Joon, et al.
Publicado: (2014)

251 Interferon-Gamma Release Assay—Useful Tool for the Diagnosis of Pleural Tuberculosis
por: Ondrejkova, Andrea, et al.
Publicado: (2012)

Bovine Tuberculosis Epidemiology in Cameroon, Central Africa, Based on the Interferon-Gamma Assay
por: Kelly, Robert F., et al.
Publicado: (2022)

Cryptococcal mesenteric lymphadenitis in an immunocompromised host
por: Mardi, Kavita, et al.
Publicado: (2012)

Isolated Aspergillus thyroiditis in an immunocompromised patient
por: Chung, Sungjin, et al.
Publicado: (2010)

COVID-19 vaccination in immunocompromised patients
por: Sonani, Bhavin, et al.
Publicado: (2021)

“Living with COVID”—implications for immunosuppressed and immunocompromised
por: Nune, A., et al.
Publicado: (2022)

Risk of Tuberculosis Among Patients on Dialysis: The Predictive Value of Serial Interferon-Gamma Release Assay
por: Shu, Chin-Chung, et al.
Publicado: (2016)

Performance of two interferon-gamma release assays for tuberculosis infection screening in Kawasaki children before immunosuppressive therapy
por: Chen, Hao, et al.
Publicado: (2023)

Fecal Microbiota Transplantation Inhibits Multidrug-Resistant Gut Pathogens: Preliminary Report Performed in an Immunocompromised Host
por: Biliński, Jarosław, et al.
Publicado: (2016)

Non-Tuberculous Mycobacteria and the Performance of Interferon Gamma Release Assays in Denmark
por: Hermansen, Thomas Stig, et al.
Publicado: (2014)

Longitudinal Evaluation of the QuantiFERON-TB Gold Plus Assay in Hospitalized COVID-19 Patients with a First Indeterminate Result: Resolution of Inflammation and Restoration of T-Lymphocyte Counts and Interferon-Gamma Production
por: Alessio, Grazia, et al.
Publicado: (2022)

Persistent Human Metapneumovirus Infection in Immunocompromised Child
por: Abed, Yacine, et al.
Publicado: (2008)

Atypical Chikungunya Virus Infections in Immunocompromised Patients
por: Kee, Adrian C.L., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_oho0s1ip9binnr8do681par324